Crocs, Inc. (NASDAQ:CROX) shares went down -3.63% in Thursday’s session, putting the price tag at $26.31 plus $1.78B in market capitalization. Earlier in the session, the stock traded between $25.44 and $26.75. Trading activity significantly improved as the volume at ready counter increased to 4,566,075 shares versus 1,823,110 in average daily trading volume over the past 20 days. So far this year, the volume has averaged about 1,102,483 shares. The stock is now 149.86% above against its bear-market low of $10.53 on December 07, 2017. It has retreated -13.26% since it’s 52-week high of $29.8 reached in December. Now the market price is up 146.12% on the year and up 108.15% YTD.

CROX’s 50 day simple moving average (SMA 50) price is $22.61 and its 200-day simple moving average (SMA 200) price is $18.72. The company’s stock currently has a total float of 65.25M shares. Its weekly volatility is hovering around 6.12% and felt 6% volatility in price over a month. On the upside, the share price will test short term resistance at around $26.89. On a downside, the stock is likely to find some support, which begins at $25.58. The failure to get near-term support could push it to $24.86.

Separately, it has been reported that multiple insider activity took place at Crocs, Inc. (CROX). Director Smach Thomas J sold 74,400 shares for $125,262 in transaction occurred on 2018/08/22. After making this transaction, the Director owns a direct stake of 1,498,416 shares, worth $3,295,643, as per the last closing price. On 2018/08/21 Hart Daniel P, Executive Vice President at CROX, dumped 20,831 shares at an average price of $20 per share. The selling total is valued at $8,600,081.

EVP, CFO, Teffner Carrie W. had invested in 7,500 shares for $349,188 through a trade on 2016/08/24. Following this activity, the insider holds 66,375 shares worth $9,187,136 as of recent close. Wall Street’s most bullish Crocs, Inc. (NASDAQ:CROX) analysts are predicting the share price to blow past $33 per share during the next 12 months. The current median share price forecast by them is $29, suggesting that the stock could increase 10.22% in that time frame. The average price target of $28.8 calls for a nearly 9.46% increase in the stock price.

It had seen a positive analyst call from Susquehanna, which upgraded the stock from Negative to Neutral on November 12. Analysts at Pivotal Research Group, maintained the company shares at Buy on November 09 but switched target price from $25 to $32. Brokerage firm Pivotal Research Group, looks cautious as they stick to prior recommendation of Buy, in a call on November 06. However, they did change the target price from $21 to $25.

When looking at valuations, Crocs, Inc. (CROX) has a pricey P/E of 76.93x as compared to industry average of 21.2x. Moreover, it trades for 32.16 times the next 12 months of expected earnings. Also, it is trading at rather expensive levels at just over 9.04x price/book and 1.67x price/sales. Compared to others, Crocs, Inc. is in a different league with regards to profitability, having net margins of 5.1%. To put some perspective around this, the industry’s average net margin is 7.49%. CROX’s ROE is 28.7%, which is also considerably better than the industry’s ROE of 13.18%. It’s also very liquid in the near term, with a current ratio of 2.6. The stock has a debt/capital of 0.

Shares of Crocs, Inc. (CROX) have gained 27.3% since the company’s last earnings report. Over the past 12 fiscal quarters, Crocs, Inc. (NASDAQ:CROX) has topped consensus earnings estimates in 8 quarters (66%), missed earnings in 4 quarters (33%), whereas at 0 occasion EPS met analyst expectations. Revenue for the recent quarter stood at $261.06 million, up 7% on last year and above the $246.4 million predicted by analysts. For this quarter, Wall Street analysts forecast revenue in a range of $199.4 million to $205.19 million, which should be compared with $187.6 million generated last year. EPS is seen in a range of -$0.31 to -$0.21, against the -$0.31 reported a year ago.